In a randomized control trial of infants <32 weeks gestational age, repeated dosing of intramuscular EPO decreased the incidence of Bell stage II and III NEC by 36 weeks postmenstrual age [91]. The gene discussed is EPO; the disease is necrotizing enterocolitis.